Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in ...

Clinical Features. Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, accounting for 85% of all such tumors. [1] The tumor usually affects adults but may also occur in younger ...

Several components of the hedgehog (Hh) pathway are crucial to basal cell carcinoma (BCC) tumorigenesis. Primary cilia have emerged as key organelles in Hh signal transduction in mammalian systems ...

B asal cell carcinoma (BCC) is the most common type of skin cancer, arising from the basal cells located in the epidermis, the skin’s outermost layer. Despite its prevalence, BCC is often less ...

Not all cancers are carcinoma. Other types of cancer that aren't carcinomas invade the body in different ways. Those cancers begin in other types of tissue, such as: Basal cell carcinoma.

Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, ...

Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-small ...

which aims to evaluate the efficacy of D-MNA for treating basal cell carcinoma (BCC) of the skin. The company plans to conduct an interim data analysis by the end of Q1 2025 and will submit its ...

Clinical Trial Design The clinical study, SKNJCT-003, is designed to be a randomized, double-blind, placebo-controlled (P-MNA), multi-center study enrolling up to 60 subjects presenting with BCC ...